1. Home
  2. SKM vs NUVL Comparison

SKM vs NUVL Comparison

Compare SKM & NUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SK Telecom Co. Ltd.

SKM

SK Telecom Co. Ltd.

HOLD

Current Price

$28.06

Market Cap

12.5B

ML Signal

HOLD

Logo Nuvalent Inc.

NUVL

Nuvalent Inc.

HOLD

Current Price

$98.09

Market Cap

8.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SKM
NUVL
Founded
1984
2017
Country
South Korea
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.5B
8.1B
IPO Year
1999
2021

Fundamental Metrics

Financial Performance
Metric
SKM
NUVL
Price
$28.06
$98.09
Analyst Decision
Hold
Strong Buy
Analyst Count
1
15
Target Price
N/A
$135.33
AVG Volume (30 Days)
1.9M
436.1K
Earning Date
01-01-0001
05-27-2026
Dividend Yield
1.87%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$4.34
N/A
Revenue Next Year
$1.87
$1,064.25
P/E Ratio
$31.64
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.66
$55.54
52 Week High
$33.71
$113.02

Technical Indicators

Market Signals
Indicator
SKM
NUVL
Relative Strength Index (RSI) 44.83 42.01
Support Level $20.03 $73.22
Resistance Level $33.71 $107.13
Average True Range (ATR) 1.00 3.82
MACD -0.56 -0.35
Stochastic Oscillator 3.80 19.08

Price Performance

Historical Comparison
SKM
NUVL

About SKM SK Telecom Co. Ltd.

SK Telecom is South Korea's largest wireless telecom operator, with 32 million mobile customers. The firm also owns SK Broadband (formerly Hanaro Telecom), which has 7.2 million broadband customers and 9.5 million pay TV customers (6.7 million IPTV and 2.8 million Cable TV). While the firm also purchased stakes in businesses in security and semiconductor memory production as well as developing e-commerce and internet platform businesses, these were all spun off into the separate, SK Square business in November 2021. The company was formed after SK Group purchased KT's mobile business in 1994.

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of its operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

Share on Social Networks: